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Abstract
Background: The World Health Organisation recognises the importance of palliative care in an African setting.
Despite this services are often patchy and inconsistent, and many operate at health centre and/or community
level. Few reports from hospital based palliative care services in sub-Saharan Africa exist in the current literature. As
part of its activities Tiyanjane Clinic has been providing hospital based palliative care to patients at Queen Elizabeth
Central Hospital, a large government tertiary referral institution, in the Southern region of Malawi since 2003, caring
for patients with HIV, cancer and other non-malignant palliative diagnoses.
Methods: A retrospective review of case notes for all in-patients seen by Tiyanjane Clinic over a six month period
(April-Sept 2009) was undertaken.
Results: A total of 177 patients were seen, for whom 137 case notes were available (77%). 58% of patients were
male, 42% female. The average age of patients was 39.1 years (range 15-92 years). 54% of patients were HIV
positive, with 34% on ARV drugs at the time of care. 42% of patients had HIV related diagnoses, including AIDS
defining malignancies, 48% had (non AIDS related) cancers and 9% had other palliative diagnoses. The mean age
of patients with HIV related diagnoses was 34 years, for cancer patients it was 48 years. Pain was the most
commonly reported symptom (74%), with 56% of patients requiring oral morphine. The mean daily dose of
morphine was 30 mg/day (range 9-100 mg). 65% of patients were discharged home, 26% of patients died during
admission.
Conclusions: The palliative care population in this setting is relatively young, especially among patients with HIV
related diagnoses. HIV and cancer are the main diagnostic groups. Pain is the most commonly reported symptom,
with oral morphine frequently required. Health workers require access to and knowledge of oral morphine in order
to provide appropriate assistance to patients under their care.
Background
Palliative care improves the quality of life for patients
and families who face life-threatening illnesses, from
diagnosis through to end of life and bereavement [1]. In
the developing world the majority of cancer patients
present at an advanced stage of disease making palliative
care an essential part of management [2]. Palliative care
has also been shown to play a critical role in the man-
agement of other chronic conditions, including HIV and
AIDS, even in places where anti-retroviral drugs (ARVs)
are available [3,4]. Despite recognition from the World
Health Organisation (WHO) of the importance of pro-
viding palliative care, studies show that the service pro-
vision in Africa remains patchy and inconsistent [5-7].
Tiyanjane Clinic was established in 2003 with the aim
of improving the quality of life of patients at Queen Eliza-
beth Central Hospital (QECH), the largest government
hospital in Malawi with over 1200 beds, and the sur-
rounding communities. Malawi is one of the most
resource poor countries in sub-Saharan Africa (SSA),
with around one million of its population living with HIV
and an estimated 40% of the population living in extreme
poverty [8]. Per capita spending on health is around $64
per year [9]. These problems are exacerbated by critical
human resource shortages in the health care sector [10].
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patients with HIV and AIDS related illnesses Tiyanjane
Clinic provides palliative care services for in-patients
referred from the adult medical wards at QECH. The
clinic is situated within the hospital and referrals are
taken from clinicians working on those wards using a
structured referral form. Other aspects of the service,
not reported on here, include HIV counseling and test-
ing, out-patient clinics, community visits and a commu-
nity based service at a nearby government run health
centre. The Clinic team comprises three clinicians, three
nurses, one HIV counselor and two support staff. Gov-
ernment health services, through the hospital, district
health services and the local medical school, support the
majority of the costs.
This review looks at six months of in-patient palliative
care services at Tiyanjane Clinic.
Methods
A retrospective paper based case-notes review of in-
patients managed by Tiyanjane Clinic over a six month
period (April - September 2009) was undertaken. An
ethics waiver from the University of Malawi, College of
Medical Research and Ethics was obtained to perform our
study. Clinic records were used to generate a list of all in-
patients at QECH who were seen by Tiyanjane over this
time period. There were no exclusion criteria with all
patients seen over this time period included in the study.
Initially paper notes, the principle source of patient
records, and then the clinic’s computer database were
searched to obtain comprehensive records for each
patient. Each set of notes was used to identify data on
patient age, sex, diagnosis, reported symptoms, medica-
tions prescribed, length of stay and outcome. All records
were anonymous for identifying patient details. The data
was recorded in and analysed using Microsoft Excel.
Results
A total of 177 patients were seen over a six month period.
Records were obtained for 137 of these patients (77%),
with the remaining 40 patient’s records unobtainable. Of
these 137 there were 17 patients (12%) for whom only
computer records were available.
79 patients were male (58%) and 58 were female (42%).
The mean age of the patients was 39.1 years (range 15 -
92 years). 74 patients (54%) were known to be HIV posi-
tive, with 25 (34%) already on ARVs at time of care.
(Table 1 and 2, Figures 1 and 2)
66 patients (48%) had a diagnosis of (non-AIDS
related) cancer. 40 patients (29%) had an AIDS defining
malignancy (as defined by the WHO clinical staging of
HIV/AIDS for adults and adolescents [11]), mainly
Kaposi’s sarcoma (37patients). 18 (13%) had other diag-
noses related to HIV, including cryptoccocal meningitis,
lactic acidosis secondary to ARVs, “advanced HIV” and
progressive multifocal leukoencephalopathy, giving a
total of 58 patients (42%) with HIV related diagnoses.
The remaining 13 patients (9%) had other palliative
diagnoses, including heart failure and/or cardiomyopa-
thy (4 patients), liver and/or renal failure (2 patients)
and subarachnoid haemorrhage (2 patients). (Figure 3)
The mean age of patients with HIV related diagnoses
was 34 years (range 15-53). For cancer patients the
mean age was 48 years (range 15-92). (Figure 1)
Pain was the most commonly reported symptom (74%).
Other common symptoms were shortness of breath (50%),
being unable to walk (44%) and weakness (37%). Four
patients (3%) reported symptoms of anxiety/depression.
83% of cancer patients reported pain, 71% of those with
HIV related diagnoses reported pain. (Figure 4)
Analgesic drugs were prescribed to 117 of the patients
(85%) during admission. 77 patients (56%) were prescribed
oral morphine (liquid and/or tablets). The mean total daily
dose of morphine was 30 mg (range of 9-100 mg). 64% of
cancer patients were prescribed morphine; mean daily
dose 34.0 mg (range 15-100 mg). 52% of patients with
HIV related diagnoses were prescribed morphine, mean
daily dose 25.5 mg (range 9-60 mg).
The average length of involvement by the palliative
care team was 6.3 days (range 1-39 days). 89 patients
(65%) were discharged home and 36 (26%) died on the
ward. 33% of the patients with HIV related diagnoses
died on the ward, 23% of cancer patients died on the
ward. Follow-up was planned for 45 patients (51% of
those discharged), with 26 of these patients actually
attending. An additional 10 patients for who arranged
follow-up wasn’t documented were also seen again by
clinic, making a total of 36 patients (40% of those dis-
charged) followed-up after discharge. (Table 3 and 4)
Discussion
This case note review provides a good insight into a
hospital based palliative care service in a low resource
setting, with a high HIV prevalence, in SSA. Palliative
care has recently been recognised by the Ministry of
Health in Malawi as part of a minimum standard of
care for all tertiary institutions (Dr Jane Mallewa,
QECH, personal communication). This paper provides
useful data of some of the service needs that would
Table 1 Patient sex ratios
All pts (%) HIV pts (%) Cancer pts (%) Other pts (%)
Sex
Male 79 58 33 57 40 61 6 46
Female 58 42 25 43 26 39 7 54
Total 137 100 58 100 66 100 13 100
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the same or similar settings.
The mean age of in-patients seen by the palliative care
team was 39.1 years; the average life expectancy in
Malawi is 53 years [12]. Other studies of palliative care
populations from around the world have found a mean
age of 66 years in the UK, a median of 62 years in Tai-
wan and a mean of 42.7 years from a hospital based pal-
liative care service in South Africa, highlighting the
lower age range which maybe expected by those provid-
ing palliative care in SSA [13-15]. The difference in age
between the patients with HIV related diagnoses and
cancer patients (33 years compared with 48 years)
emphasises the impact of the HIV epidemic in our set-
ting. Patients are being referred to palliative care ser-
vices during what should be expected to be their most
productive working years. This places a particular bur-
den on families and has implications for patients and
carers alike.
It is important to note however that more than one in
five of the patients seen were either over the age of 60
(12%) or under the age of 25 (11%). Health care profes-
sionals need to be aware of the special needs and per-
spectives of both adolescents and young adults, and the
elderly facing life threatening illnesses in this setting.
At the time of review referrals were predominately
taken from general medical adult wards. More recently
an outreach service to general surgical, gynaecology and
other specialist wards in the hospital is being developed
utilising a series of ‘link nurses’ based on the specialist
wards who are trained to undertake palliative care
assessments. There is a separate paediatric palliative
care team operating at the hospital. The total number of
patients requiring palliative care across all hospital spe-
cialties at our hospital during this period is likely to
have been much higher.
HIV was common, with just over half of the patients
HIV positive. Malawi has an HIV prevalence of 11.9%,
although the urban prevalence is known to be higher at
around 17% [16]. Recent studies in QECH have found
an HIV prevalence of 70% among medical in-patients
[17]. Only a third of the HIV positive patients were on
ARVs. Reasons for patients not being on ARVs when
being seen by the palliative care team may include this
presentation being their first presentation of disease,
and therefore the initial diagnosis of HIV, or the pre-
sence of other co-morbidities, such as TB, delaying the
initiation of ARVs until a later date. ARVs have been
freely available in the public sector in Malawi since
2004, with an estimated 300,000 people eligible. Cur-
rently around 200,000 are on treatment [18]. More work
Figure 1 Patient age range, by diagnostic group. Figure 2 HIV status (all patients).
Table 2 HIV status of patients
All pts (%) HIV pts (%) Cancer pts (%) Other pts (%)
Negative 44 32 0 0 37 56 7 54
Positive 74 54 58 100 13 20 3 23
Unknown 19 14 0 0 7 23 3 11
HIV pts on ARVs?
On ARVs 25 34 38 66 5 38 3 100
Not on ARVs 46 62 17 29 8 62 0 0
Unknown 1 1 1 2 0 0 0 0
Stopped 2 3 2 3 0 0 0 0
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is still needed to further increase the number of eligible
people receiving ARVs. However it is important to
emphasize that palliativec a r es e r v i c e sm a ys t i l lb e
required for patients with HIV who are taking ARVs,
especially for those who have treatment related side
effects, poor adherence or HIV related malignancies.
There was a high prevalence of pain among patients
with cancer (83%) and with HIV related diagnoses
(71%). Other symptoms were also common among both
sets of patients, which is consistent with previous find-
ings that symptoms among HIV/AIDS patients are simi-
lar to those of patients with terminal cancer [19]. 56%
of patient’s required oral morphine. The mean daily
dose of morphine prescribed by palliative care personnel
in this setting, 30 mg/day, was much lower than the
average dose of 100-250 mg/day found by a 2007
Cochrane review of opiate prescribing in palliative care
[20]. Reasons for the lower doses are not clear and are
likely to be multi-factorial. Despite the fact that it has
repeatedly be shown to be safe and cost effective to use
in low resource setting, with negligible rates of iatro-
genic addiction, morphine is underutilised in numerous
low resource settings [7,21]. Reasons for this include
restrictive legislation, drug availability, lack of training,
and fears over addiction and dependence [6,22].
A short mention should be made regarding symptoms of
anxiety and depression. According to our results these
symptoms were only reported by 4 patients. Other studies
estimate that between 7% and 30% of palliative patients
suffer from depression [23,24]. HIV patients in South
Africa were found to exhibit high levels of psychological
symptoms, with 55% of patients reporting depression and
49% anxiety [25]. There is little recognition of, and in-fact
no word in Chichewa, the local language in Malawi, for
depression. Whether our findings represent a true lack of
symptoms or reflect under reporting in our records is not
clear. Further work into evaluating psychological symp-
toms among our patient population using more in-depth
screening tools would be helpful to address whether we
are adequately screening for, and therefore responding
appropriately to, these symptoms.
Hospital in-patient stays were short (mean 6.3 days).
Ongoing provision of holistic care in the community is
therefore vital, with family members, community home
based care teams and community leaders all playing their
part. Through collaboration with NGOs and community
based organisations the Ministry of Health in Malawi has
a clear system for training of home based care volunteers,
and numerous groups operate in all regions of the country.
Our programme works with over 100 community based
volunteers in a nearby township area to provide ongoing
care after discharge from hospital. Programmes such as
the integrated community based home care (ICHC) mod-
els from South Africa [7] provide some ideas as to how
such programmes may be implemented, though the dra-
matic paucity of resources for health care and of human
resource in Malawi may limit replication.
Only 40% of patients discharged were followed up by
the palliative care team. Transport has been cited by
others as a major barrier in access to health services in
resource poor settings [26]. As a central teaching hospi-
tal patients are often referred from distant health facil-
ities far from the clinic. There is no government system
of welfare payments to support palliative care patients
in Malawi, with loss of income due to disease meaning
f u n d sf o rt r a n s p o r tt oa t t e n df o l l o w - u p ,a l o n gw i t h
Table 3 Patient outcomes
All
pts
(%) HIV
pts
(%) Cancer
pts
(%) Other
pts
(%)
Discharged 89 65 29 50 49 74 11 85
Died 36 26 19 33 15 23 2 15
Unknown 12 9 10 17 2 3 0 0
Figure 3 Patient diagnoses.
Figure 4 Prevalence of reported symptoms by diagnostic
group.
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tive care training at district and health centre level is
vital to assist with timely and appropriate follow-up for
patients in this setting.
Limitations
This was a retrospective study. Despite careful searching
23% of data sheets (either in the computer or paper
based clinic systems) were not found. Prospective data
collection could have avoided this problem.
It is beyond the remit of a case note review to address
the efficacy and quality of these interventions. Qualita-
tive research concentrating on patients, and their
families, experiences of the care they receive is needed
to determine how care impacts upon the quality of life
of users, and to help develop the service offered in
response to these findings.
Conclusions
This study provides insight into the problems faced by
palliative care in- patients in a low resource, high HIV
prevalence setting. Palliative care patients are younger
than in settings of low HIV prevalence and many are
taking ARV medications for HIV. Cancer and HIV/
AIDS are the main diagnostic groups. Pain is a common
symptom. Oral morphine is required frequently, but at
relatively low doses, to control pain. Rates of depression
are poorly recorded in routine assessments. Difficulties
in following-up patients after discharge mean that out-
reach support and training of staff in district areas to
provide palliative care is important to increase access to
all patients in need of palliative care services.
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